PL EN
 
6/2009 vol. 63
Pobierz cytowanie
Cewkowo-środmiąższowe zapalenie nerek u chorej przewlekle zażywającej furosemid
Anna Bekier-Żelawska 1
,
 
Jan Duława 1
 
 
 
Więcej
Ukryj
1
Klinika Chorób Wewnętrznych i Metabolicznych SUM w Katowicach
 
 
Autor do korespondencji
Anna Bekier-Żelawska   

Klinika Chorób Wewnętrznych i Metabolicznych SUM, 40-635 Katowice, ul. Ziołowa 45/47; tel. 032 359 83 00 fax. 032 252 35 93
 
 
Ann. Acad. Med. Siles. 2009;63:81-85
 
Artykuł (PDF)
Referencje (23)
 
SŁOWA KLUCZOWE
wapnica nerek
cewkowo-śródmiąższowe zapalenie nerek
Furosemid
 
STRESZCZENIE
W przedstawionej pracy omówiono przypadek cewkowo-śródmiąższowego zapalenia oraz wapnicy nerek u chorej długotrwale zażywającej diuretyk pętlowy (furosemid). Powikłania przewlekłej terapii furosemidem, prowadzące do zaburzeń gospodarki wapniowej, skutkują m.in. powstawaniem kamicy i wapnicy nerek . Leczeniem z wyboru, w uzasadnionych przypadkach, jest całkowite odstawienie leku moczopędnego.
ISSN 0208-5607
REFERENCJE (23)
1.
Albright F, Baird PC, Cope O, Bloomberg E. Studies on the physiology of the parathyroid glands. IV. Renal complications of hyperparathyroidism. Am J Med Sci. 1934;187(1):49-65.
Google Scholar
 
 
2.
Tykarski A. Manitius J. Diuretyki w leczeniu nadciśnienia tętniczego i chorób nerek Gdańsk 2006. Wydanie I.
Google Scholar
 
 
3.
Hufnagle KG, Khan SN, Penn D, et al. Renal calcifi cations: A complication of long-term furosemide therapy in pre-term infants. Pediatrics 1982 Sep; 70(3):360-3.
Google Scholar
 
 
4.
Kim YG, Kim B, Kim MK, Chung SJ, Han HJ, Ryu JA, Lee YH i wsp. Medullary nephrocalcinosis associated with long-term furosemide abuse in adults. Nephrol Dial Transplant. 2001 Dec;16(12):2303-9.
Google Scholar
 
 
5.
Jennings M, Shortland JR, Maddocks JL. Interstitial nephritis associated with frusemide. J R Soc Med. 1986 Apr;79(4):239-40.
Google Scholar
 
 
6.
Park CW, You HY, Kim YK, Chang YS, Shin YS, Hong CK, Kim YC, Bang BK. Chronic tubulointerstitial nephritis and distal renal tubular acidosis in a patient with frusemide abuse. Nephrol Dial Transplant. 2001 Apr;16(4):867-9.
Google Scholar
 
 
7.
Pattaragarn A, Fox J, Alon US. Eff ect of the calcimimetic NPS R-467 on furosemide-induced nephrocalcinosis in the young rat. Kidney International (2004) 65, 1684–1689.
Google Scholar
 
 
8.
Pressler CA, Heinzinger J, Jeck N, Waldegger P, Pechmann U, Reinalter S, Konrad M i wsp. Late-onset manifestation of antenatal Bartter syndrome as a result of residual function of the mutated renal Na+-K+-2Cl- co-transporter. J Am Soc Nephrol. 2006 Aug;17(8):2136-42.
Google Scholar
 
 
9.
Balogun RA, Adams ND, Palmisano J, et al. Focal segmental glomerulosclerosis, proteinuria and nephrocalcinosis associated with renal tubular acidosis. Nephrol Dial Transplant. Feb 2002;17(2):308-10.
Google Scholar
 
 
10.
Saarela T, Lanning P, Koivisto M, Paavilainen T. Nephrocalcinosis in full-term infants receiving furosemide treatment for congestive heart failure: a study of the incidence and 2-year follow up. Eur J Pediatr. 1999 Aug;158(8):668-72.
Google Scholar
 
 
11.
Solivetti FM, Paganelli C, Zoff oli M, Bacaro D, Quintigliano D, Nasrollah N. Nephrocalcinosis induced by long-term therapy with furosemide. J Clin Ultrasound. 1997 Nov-Dec;25(9):519-20.
Google Scholar
 
 
12.
Alon US. Nephrocalcinosis. Curr Opin Pediatr. 1997 Apr;9(2):160-5. Review.
Google Scholar
 
 
13.
Kugelman A, Durand M, Garg M. Pulmonary eff ect of inhaled furosemide in ventilated infants with severe bronchopulmonary dysplasia. Pediatrics. 1997 Jan;99(1):71-5.
Google Scholar
 
 
14.
Pope JC 4th, Trusler LA, Klein AM, Walsh WF, Yared A, Brock JW. The natural history of nephrocalcinosis in premature infants treated with loop diuretics. 3rd.J Urol. 1996 Aug;156(2 Pt 2):709-12.
Google Scholar
 
 
15.
Alon US, Kaplan RA, Gratny LL, Nichols MA. Histological long-term outcome of furosemide-induced nephrocalcinosis in the young rat. Pediatr Nephrol. 1996 Apr;10(2):191-4.
Google Scholar
 
 
16.
Alon US, Scagliotti D, Garola RE. Nephrocalcinosis and nephrolithiasis in infants with congestive heart failure treated with furosemide. J Pediatr. 1994 Jul;125(1):149-51.
Google Scholar
 
 
17.
Kenney IJ, Aiken CG, Lenney W. Frusemide-induced nephrocalcinosis in very low birth weight infants. Pediatr Radiol. 1988;18(4):323-5.
Google Scholar
 
 
18.
Myracle MR, McGahan JP, Goetzman BW, Adelman RD. Ultrasound diagnosis of renal calcifi cation in infants on chronic furosemide therapy J Clin Ultrasound. 1986 May;14(4):281-7.
Google Scholar
 
 
19.
Tajiri J, Nakayama M, Sato T, Isozaki S, Uchino K. Pseudo-Bartter’s syndrome due to furosemide abuse: report of a case and an analytical review of Japanese literature. Jpn J Med. 1981 Jul;20(3):216-21.
Google Scholar
 
 
20.
Lin MT, Tsau YK, Tsai WY, Tsai WS, Lu FL, Hsiao PH, Chen CH. Nephrocalcinosis in childhood. Acta Paediatr Taiwan. 1999 Jan-Feb;40(1):27-30.
Google Scholar
 
 
21.
Konrad M, Vollmer M, Lemmink HH, van den Heuvel LP, Jeck N, Vargas-Poussou R, Lakings A I wsp. Mutations in the chloride channel gene CLCNKB as a cause of classic Bartter syndrome. J Am Soc Nephrol. 2000 Aug;11(8):1449-59.
Google Scholar
 
 
22.
Karolina Kędzierska, Kazimierz Ciechanowski, Maria Pietrzak-Nowacka. Pseudo-Gitelman’s syndrome as a consequence of loop diuretics abuse. Polskie Archiwum Medycyny Wewnętrznej 2001, 105(6), s.501-504.
Google Scholar
 
 
23.
Kurschat C, Heering P, Grabensee B. Gitelman’s syndrome: an important diff erential diagnosis of hypokalemia Dtsch Med Wochenschr. 2003 May 30;128(22):1225-8.
Google Scholar
 
 
Udostępnij
Wyślij mailem
Indeksy
 
Indeks słów kluczowych
Indeks dziedzin
Indeks autorów
eISSN:1734-025X
Journals System - logo


© 2006-2024 Journal hosting platform by Bentus
Scroll to top